Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

LCTXLCTX
28 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in LINEAGE CELL THERAPEUTICS IN

NORTHERN TRUST CORP holds 1.7M shares of LCTX (LINEAGE CELL THERAPEUTICS IN), worth $2.2M as of 2026-Q2. The position was increased (+231.9% shares). LCTX represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$2.2M

Current Shares

1.7M

Total Value Change

+$993,213

Total Shares Change

+455,292

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+231.9%
$2.2M0.0%$1.31
42
2026-Q1
Increased
499,127
+4.1%
$788,6210.0%$1.58
26
2025-Q4
Increased
479,273
+8.1%
$800,3860.0%$1.67
27
2025-Q3
Decreased
443,352
-13.2%
$749,2640.0%$1.69
0
2025-Q2
Decreased
510,462
-66.8%
$463,1940.0%$0.91
0
2025-Q1
Increased
1.5M
+20.8%
$695,2760.0%$0.45
29
2024-Q4
Decreased
1.3M
-0.0%
$640,4320.0%$0.50
0
2024-Q3
Increased
1.3M
+7.0%
$1.2M0.0%$0.91
27
2024-Q2
Decreased
1.2M
-3.3%
$1.2M0.0%$1.00
0
2024-Q1
Increased
1.2M
+3.1%
$1.8M0.0%$1.48
27
2023-Q4
Decreased
1.2M
-0.7%
$1.3M0.0%$1.09
0
2023-Q3
Increased
1.2M
+9.1%
$1.4M0.0%$1.18
28
2023-Q2
Increased
1.1M
+365.3%
$1.6M0.0%$1.41
41
2023-Q1
Increased
237,083
+6.1%
$355,6250.0%$1.50
25
2022-Q4
Unchanged
223,450
0.0%
$261,4370.0%$1.17
0
2022-Q3
Increased
223,450
+10.7%
$252,0000.0%$1.13
26
2022-Q2
Decreased
201,775
-80.4%
$319,0000.0%$1.58
0
2022-Q1
Decreased
1M
-4.6%
$1.6M0.0%$1.54
0
2021-Q4
Decreased
1.1M
-27.8%
$2.6M0.0%$2.45
0
2021-Q3
Decreased
1.5M
-8.1%
$3.8M0.0%$2.52
0
2021-Q2
Increased
1.6M
+449.7%
$4.6M0.0%$2.85
43
2021-Q1
Increased
296,293
+13.1%
$696,0000.0%$2.35
28
2020-Q4
Decreased
262,029
-2.6%
$461,0000.0%$1.76
0
2020-Q3
Increased
269,056
+10.7%
$252,0000.0%$0.94
26
2020-Q2
Decreased
243,135
-81.0%
$211,0000.0%$0.87
0
2020-Q1
Increased
1.3M
+10.8%
$1.1M0.0%$0.83
28
2019-Q4
Decreased
1.2M
-3.6%
$1M0.0%$0.89
0
2019-Q3
New
1.2M
-
$1.2M0.0%$0.98
35

Other major holders of LCTX: BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used